Jan 9, 20264 CDMOs to watch in 2026 | Rentschler Biopharma, VarmX team on coagulation therapy

Jan 8, 2026Daiichi Sankyo’s $1.9B investment | Ardena, Nouveau Biosciences team on nanomedicine

Jan 7, 2026Taking radiopharma to the next level | ProBioGen, Zag Bio form CMC partnership

Jan 6, 20262026 pharma manufacturing outlook | Skye licenses Halozyme’s drug delivery tech

Dec 31, 2025Top podcast interviews of 2025

Dec 30, 2025Top regulatory stories of 2025

Dec 24, 2025Positive outlook for global CDMOs | Fujifilm’s first antibody drug manufacturing site in Japan

Dec 23, 2025Trump secures pricing deals with more drugmakers | Samsung Biologics buys first US facility

Dec 20, 20252025’s historic US pharma manufacturing investment | Minaris, CGT Catapult team on viral vectors

Dec 19, 2025Novo Nordisk’s problems at former Catalent site continue | Alcami adds manufacturing capacity

Dec 18, 2025Lonza to benefit from supply, demand trends | Alnylam’s $250M biomanufacturing expansion

Dec 17, 2025Startup looks to digitize molecule creation | Thermo Fisher aims to boost E. coli biomanufacturing

Dec 16, 2025BIOSECURE Act to further fuel Indian CRDMOs | Novartis breaks ground on NC expansion

Dec 13, 2025Cambrex targets fast-growing peptide market | Lupin teams to scale peptide supply chain

Dec 12, 2025Manufacturing, supply chain risks in 2026 | Charles River, ElevateBio join Akadeum’s new CDMO alliance

Dec 11, 2025Lilly to build $6B Alabama plant to manufacture APIs | Bora, Corealis unite on oral solid dose

Dec 10, 2025Ardena’s purchase of Catalent site pays dividends | CSL’s $1B flu vaccine plant in Australia

Dec 9, 2025FDA-cleared automation transforms blood processing | HP, mAbxience target biomanufacturing

Dec 6, 2025Will US deal with UK boost pharma investment in that country? | AI drug development teaming

Dec 5, 2025States lure biomanufacturers with financial incentives | WuXi Biologics to expand in Middle East

Dec 4, 2025India’s Sun Pharma invests in new site amid FDA scrutiny | Thermo Fisher expands in Asia

Dec 3, 2025UK gets pharma tariff exemption from Trump | Economics of US generic drug manufacturing

Dec 2, 2025Manufacturing building boom’s incentives, challenges | Lonza sells micronization facility

Nov 27, 2025GLP-1s fuel growth for Agilent’s CDMO business | GSK upgrades legacy motors at facility

Nov 26, 2025Novartis to cut 550 jobs as it automates Swiss plant | US biomanufacturing center of excellence

Latest Edition